Too much of a risk for Alzheimers Drug

Quote
























Wait primary care and specialty targets? Sorry, but once you go specialty you don't go back. I knew those small territories were a red flag...These "counter parts" are they the specialty people and we're the goofers?
 






anonymous said:
Wait primary care and specialty targets? Sorry, but once you go specialty you don't go back. I knew those small territories were a red flag...These "counter parts" are they the specialty people and we're the goofers?
Click to expand...

This is what I was afraid of. However, $200k to d*ck around in pc offices all day isn't the worst way to make a living.
 






200k is a bit of a pipe dream for the territory pod rep positions. Maybe more accurate for reimbursement rep positions. Like others have mentioned, unless you are high risk lay off or out of a job, this position is very iffy. For starters no guarantee of a product anytime soon, mostly big pharma clone DMs, being in a pod with PCP targets....... do your homework. Looks to be desperate escape job that will blow up within 1st 6 months.
 






anonymous said:
200k is a bit of a pipe dream for the territory pod rep positions. Maybe more accurate for reimbursement rep positions. Like others have mentioned, unless you are high risk lay off or out of a job, this position is very iffy. For starters no guarantee of a product anytime soon, mostly big pharma clone DMs, being in a pod with PCP targets....... do your homework. Looks to be desperate escape job that will blow up within 1st 6 months.
Click to expand...

If you talk to Biogen koolaid drinkers approval is a "slam dunk". Of course that's what everyone who works there is hoping for. And the world needs a new drug for this devastating disease IF it works. And in this case it's a BIG IF. 7 out of 10 analysts give it a very slim chance of approval w/o more data/studies which will take time. And during that time those who joined or transferred from a different division within the company will be out of a job. So as the poster above says doing your homework is critical.
 












anonymous said:
This division is going to end up just like Intercept. Always such a risk to accept prior to a drug approval. Good luck.
Click to expand...

l know folks who went there. And for their sake and more importantly the sake of patients suffering I hope the drug is approved. But hope won’t get it done and unfortunately the data is not strong
 






anonymous said:
l know folks who went there. And for their sake and more importantly the sake of patients suffering I hope the drug is approved. But hope won’t get it done and unfortunately the data is not strong
Click to expand...
Data is very weak. Most experts feel, at best, more studies will be needed. More studies would mean at least a couple years of longer delay, and Biogen will simply cut bait with all the new hires. Even if by some miracle the drug is approved, how much can you charge for such modest results?
 


















Just saw the opening for “Cambridge” and thought, isn’t this a home office backyard territory? I last applied to Biogen in 1998 for Avonex and turned down the hiring manager who was a dick. What’s it like there now?
 






























anonymous said:
This will be doing a deal with the devil.
Click to expand...

How so? I have a good-not-great situation at my current gig, but I am considering applying for this position.

I don't see any downside should the FDA approve the med.

Sure, it's expensive & the data isn't ideal but the fact of the matter is that there aren't many options for AD patients.
 






Why would you leave your current job if it’s specialty and stable to come here? Have you not read thru these Biogen threads? This will be typical big pharma shit show on wheels. Cloned big pharma DMs, PITA counterparts, Micro managed metrics, primary care call points........ if these things get you excited, go for it! LMAO
 






Top Bottom
Back
Quote